These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 22974254)

  • 1. The effect of oral prostaglandin analogue on painful diabetic neuropathy: a double-blind, randomized, controlled trial.
    Shin S; Kim KJ; Chang HJ; Lee BW; Yang WI; Cha BS; Choi D
    Diabetes Obes Metab; 2013 Feb; 15(2):185-8. PubMed ID: 22974254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C beta-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial.
    Vinik AI; Bril V; Kempler P; Litchy WJ; Tesfaye S; Price KL; Bastyr EJ;
    Clin Ther; 2005 Aug; 27(8):1164-80. PubMed ID: 16199243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metanx in type 2 diabetes with peripheral neuropathy: a randomized trial.
    Fonseca VA; Lavery LA; Thethi TK; Daoud Y; DeSouza C; Ovalle F; Denham DS; Bottiglieri T; Sheehan P; Rosenstock J
    Am J Med; 2013 Feb; 126(2):141-9. PubMed ID: 23218892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 6-month, randomized, double-masked, placebo-controlled study evaluating the effects of the protein kinase C-beta inhibitor ruboxistaurin on skin microvascular blood flow and other measures of diabetic peripheral neuropathy.
    Casellini CM; Barlow PM; Rice AL; Casey M; Simmons K; Pittenger G; Bastyr EJ; Wolka AM; Vinik AI
    Diabetes Care; 2007 Apr; 30(4):896-902. PubMed ID: 17392551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy.
    Ziegler D; Hanefeld M; Ruhnau KJ; Hasche H; Lobisch M; Schütte K; Kerum G; Malessa R
    Diabetes Care; 1999 Aug; 22(8):1296-301. PubMed ID: 10480774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: a 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.
    Rosenstock J; Brazg R; Andryuk PJ; Lu K; Stein P;
    Clin Ther; 2006 Oct; 28(10):1556-68. PubMed ID: 17157112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of lacosamide in diabetic neuropathic pain: an 18-week double-blind placebo-controlled trial of fixed-dose regimens.
    Wymer JP; Simpson J; Sen D; Bongardt S;
    Clin J Pain; 2009 Jun; 25(5):376-85. PubMed ID: 19454870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial.
    Ziegler D; Ametov A; Barinov A; Dyck PJ; Gurieva I; Low PA; Munzel U; Yakhno N; Raz I; Novosadova M; Maus J; Samigullin R
    Diabetes Care; 2006 Nov; 29(11):2365-70. PubMed ID: 17065669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral Beraprost sodium, a prostaglandin I(2) analogue, for intermittent claudication: a double-blind, randomized, multicenter controlled trial. Beraprost et Claudication Intermittente (BERCI) Research Group.
    Lièvre M; Morand S; Besse B; Fiessinger JN; Boissel JP
    Circulation; 2000 Jul; 102(4):426-31. PubMed ID: 10908215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of oral beraprost sodium, a prostaglandin I2 analogue, on endothelium dependent vasodilatation in the forearm of patients with coronary artery disease.
    Ohata S; Ishibashi Y; Shimada T; Takahashi N; Sugamori T; Sakane T; Hirano Y; Oyake N; Murakami Y; Higami T
    Clin Exp Pharmacol Physiol; 2006 Apr; 33(4):381-7. PubMed ID: 16620305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lacosamide in painful diabetic neuropathy: an 18-week double-blind placebo-controlled trial.
    Shaibani A; Fares S; Selam JL; Arslanian A; Simpson J; Sen D; Bongardt S
    J Pain; 2009 Aug; 10(8):818-28. PubMed ID: 19409861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beraprost sodium, an orally active prostaglandin I(2) analog, improves renal anemia in hemodialysis patients with peripheral arterial disease.
    Moriya H; Ishioka K; Honda K; Oka M; Maesato K; Ikee R; Hidaka S; Ohtake T; Kobayashi S
    Ther Apher Dial; 2010 Oct; 14(5):472-6. PubMed ID: 21175545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial.
    Jude EB; Selby PL; Burgess J; Lilleystone P; Mawer EB; Page SR; Donohoe M; Foster AV; Edmonds ME; Boulton AJ
    Diabetologia; 2001 Nov; 44(11):2032-7. PubMed ID: 11719835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled multicenter double blind trial of an oral analog of prostacyclin in the treatment of primary Raynaud's phenomenon. French Microcirculation Society Multicentre Group for the Study of Vascular Acrosyndromes.
    Vayssairat M
    J Rheumatol; 1996 Nov; 23(11):1917-20. PubMed ID: 8923366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A gastroretentive gabapentin formulation for the treatment of painful diabetic peripheral neuropathy: efficacy and tolerability in a double-blind, randomized, controlled clinical trial.
    Sandercock D; Cramer M; Biton V; Cowles VE
    Diabetes Res Clin Pract; 2012 Sep; 97(3):438-45. PubMed ID: 22497967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zonisamide in the treatment of painful diabetic neuropathy: a randomized, double-blind, placebo-controlled pilot study.
    Atli A; Dogra S
    Pain Med; 2005; 6(3):225-34. PubMed ID: 15972086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benfotiamine in diabetic polyneuropathy (BENDIP): results of a randomised, double blind, placebo-controlled clinical study.
    Stracke H; Gaus W; Achenbach U; Federlin K; Bretzel RG
    Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):600-5. PubMed ID: 18473286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Mesodiencephalic" modulation in the treatment of diabetic neuropathy.
    Lacigova S; Tomesova J; Gruberova J; Rusavy Z; Rokyta R
    Neuro Endocrinol Lett; 2013; 34(2):135-42. PubMed ID: 23645311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lacosamide in painful diabetic peripheral neuropathy: a phase 2 double-blind placebo-controlled study.
    Rauck RL; Shaibani A; Biton V; Simpson J; Koch B
    Clin J Pain; 2007 Feb; 23(2):150-8. PubMed ID: 17237664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of ubiquinone in diabetic polyneuropathy: a randomized double-blind placebo-controlled study.
    Hernández-Ojeda J; Cardona-Muñoz EG; Román-Pintos LM; Troyo-Sanromán R; Ortiz-Lazareno PC; Cárdenas-Meza MA; Pascoe-González S; Miranda-Díaz AG
    J Diabetes Complications; 2012; 26(4):352-8. PubMed ID: 22595020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.